Screener
Haemonetics HAE Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Total operating expenses | 145,345 | 138,372 |
| Operating income | 57,458 | 53,872 |
| Interest and other expense, net | (9,884) | (8,703) |
| Income before provision for income taxes | 47,574 | 45,169 |
| Provision for income taxes | 14,564 | 11,138 |
| Net income | $33,010 | $34,031 |
| Net income per common share: | ||
| Basic | $0.73 | $0.71 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's pre-tax income?
- Haemonetics (HAE) reported pre-tax income of $47.57M in Q2 2026.
- How has Haemonetics's pre-tax income changed year-over-year?
- Haemonetics's pre-tax income increased by 5.3% year-over-year, from $45.17M to $47.57M.
- What is the long-term trend for Haemonetics's pre-tax income?
- Over 3 years (2022 to 2025), Haemonetics's pre-tax income has grown at a 49.4% compound annual growth rate (CAGR), from $63.63M to $212.07M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Haemonetics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude